Explore different methods for authenticating devices on a network, from hardware addresses to advanced certificate-based ...
As India’s pharmaceutical industry moves towards becoming a 500 billion dollars global powerhouse by 2047, a new report ...
The report compares India’s non-clinical drug approval framework with regulatory practices in the US, European Union, the UK ...
In a year from now, progress is to be measured in the institutionalisation of the approach with greater regulatory acceptance ...
Experts urge India to adopt non-animal methods for pre-clinical drug testing to enhance ethics, efficiency, and scientific relevance.
Dr Reddy's, Biocon and Sun Pharma are exploring human-based testing methods that could halve drug development timelines and sharply reduce costs, while meeting global regulatory standards ...
Biocomputing research is testing living neurons for computation as scientists look for energy-efficient alternatives to ...
For decades, animals have served as the default for drug testing, but the biological divide between species is proving costly. Currently, only about 10 percent of drugs that enter human trials receive ...
Integration of the Xenometrix Ames mutagenicity test modernizes this cornerstone, regulatory-aligned NAM within the ...